Altre lingue Codexis, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 19:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
2,88 ^USD	-0,35%		-9,43%	-5,57%

30/05	CODEXIS, INC. : per Cantor Fitzgerald è Buy	ZM
14/05	Codexis, Inc. presenta i dati della sintesi enzimatica alla riunione annuale di TIDES USA e lancia i servizi di screening e ottimizzazione della RNA ligasi	CI

Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics	01/07
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets	01/07
Codexis to Participate in Jefferies Global Healthcare Conference	22/05
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week	20/05
Codexis, Inc. Presents Enzymatic Synthesis Data at TIDES USA Annual Meeting and Launches RNA Ligase Screening and Optimization Services	14/05
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting	14/05
Codexis: Q1 Earnings Snapshot	02/05
Codexis : Q1 2024 Results	02/05
Earnings Flash (CDXS) CODEXIS Posts Q1 Revenue $17.1M, vs. Street Est of $13.3M	02/05
Codexis Reports First Quarter 2024 Financial Results	02/05
Codexis, Inc. Reiterates Financial Guidance for the Fiscal 2024	02/05
Codexis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Ausblick Nestlé: Organisches Wachstum im Q1 von 2,8 Prozent erwartet	24/04
Codexis to Report First Quarter 2024 Financial Results on May 2	18/04
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board	11/04
Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board	11/04
Codexis: Q4 Earnings Snapshot	28/02
Earnings Flash (CDXS) CODEXIS Reports Q4 Revenue $26.6M, vs. Street Est of $18.9M	28/02
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	28/02
Codexis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02

Non ci sono risultati per questa ricerca